US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer.
作者信息
Shord Stacy S, Zhu Hao, Liu Jiang, Rahman Atiqur, Booth Brian, Zineh Issam
机构信息
Division of Cancer Pharmacology II (DCPII), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Division of Pharmacometrics (DPM), OCP, OTS, CDER, FDA, Silver Spring, Maryland, USA.
出版信息
CPT Pharmacometrics Syst Pharmacol. 2023 Nov;12(11):1573-1576. doi: 10.1002/psp4.13033. Epub 2023 Aug 28.
Abstract
摘要
Zotero 插件